Anna Paula Krawczyk-Santos

Anna Paula Krawczyk-Santos

Auto-generated profile, based on publicly available information

Anna Paula Krawczyk-Santos

Laboratory of Nanosystems and Drug Delivery Devices (NanoSYS), School of Pharmacy, Universidade Federal de Goiás (UFG), Goiânia, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
KRKamilla Amaral David Rocha
Kamilla Amaral David Rocha
AKAnna Paula Krawczyk-Santos
Anna Paula Krawczyk-Santos
LALígia Marquez Andrade
Lígia Marquez Andrade
LSLuana Clara de Souza
Luana Clara de Souza
RMRicardo Neves Marreto
Ricardo Neves Marreto
SStephânia Taveira
Stephânia Taveira

1 October 2017 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
LALígia Marquez Andrade
Lígia Marquez Andrade
LSLuis Antônio Dantas Silva
Luis Antônio Dantas Silva
AKAnna Paula Krawczyk-Santos
Anna Paula Krawczyk-Santos
IAIsabella Cristina de S.M. Amorim
Isabella Cristina de S.M. Amorim
PRPriscila Bianca Rodrigues da Rocha
Priscila Bianca Rodrigues da Rocha
SStephânia Taveira
Stephânia Taveira

15 February 2018 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
TGTaís Gratieri
Taís Gratieri
AKAnna Paula Krawczyk-Santos
Anna Paula Krawczyk-Santos
PRPriscila Bianca Rodrigues da Rocha
Priscila Bianca Rodrigues da Rocha
MCMarcilio Cunha-Filho
Marcilio Cunha-Filho
GGGuilherme M Gelfuso
Guilherme M Gelfuso
STStephania Fleury Taveira
Stephania Fleury Taveira
Background: Lipid nanoparticles have been extensively studied for drug delivery of antifungal drugs, especially for dermatophytosis treatments. They can accumulate in skin appendages and release drugs in a controlled manner and also increase skin moisture, due to the formation of an occlusive film. Since moisture heavily influences nail and skin permeability, these systems seem to pose great potential for antifungal drug delivery. Methods: We therefore compare skin and nail physiopathological structure and discuss the potential use of lipid nanoparticles in managing skin and nail mycoses, highlighting their unexplored use in onychomycosis. Results: Structural features become particularly relevant when treating local skin/nail disorders. Nail plate represents the most resistant barrier to the penetration of molecules. In recent years, at least 55 researches have been reported about lipid nanoparticles and, antifungal drugs. They have focused on production methods and nanoparticle ingredients influence on entrapment efficiency, fungal activity in vitro, stability, and drug release. Lipid nanoparticles such as SLN and NLC have shown great results in permeating the skin. Currently, however, there is just one study published using NLC applied directly to the nail plate. NLC containing voriconazole had a noteworthy impact on the penetration depth of a nanoencapsulated drug, which allowed its deeper penetration into porcine hooves than the unloaded drug. Conclusion: Evidence of the success of SLN and NLC in achieving high encapsulation efficiencies of antifungals and promoting cutaneous delivery indicates the potential of the systems in enhancing nail hydration and drug penetration into the nail plate.

7 March 2021 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
GAGuilherme L. Alves
Guilherme L. Alves
FTFernanda V. Teixeira
Fernanda V. Teixeira
PRPriscila Bianca Rodrigues da Rocha
Priscila Bianca Rodrigues da Rocha
AKAnna Paula Krawczyk-Santos
Anna Paula Krawczyk-Santos
LALígia Marquez Andrade
Lígia Marquez Andrade
SStephânia Taveira
Stephânia Taveira

17 December 2020 in Journal of Microencapsulation
Verified
Journal Article
Closed access
NENajla Locatelli Santos Esteves
Najla Locatelli Santos Esteves
LALígia Marquez Andrade
Lígia Marquez Andrade
AKAnna Paula Krawczyk-Santos
Anna Paula Krawczyk-Santos
BSBruno dos Santos Souza
Bruno dos Santos Souza
RMRicardo Neves Marreto
Ricardo Neves Marreto
SStephânia Taveira
Stephânia Taveira
The study aimed to develop lipid nanoparticles using excipients compatible with carvedilol (CARV) for enhanced transdermal drug delivery. Nanostructured lipid carriers (NLC) were successfully obtained and fully characterised. Franz diffusion cells were used for release and in vitro permeation studies in the porcine epidermis (EP) and full-thickness rat skin. NLC4 and NLC5 (0.5 mg/mL of CARV) presented small size (80.58 ± 1.70 and 116.80 ± 12.23 nm, respectively) and entrapment efficiency of 98.14 ± 0.79 and 98.27 ± 0.99%, respectively. CARV-loaded NLC4 and NLC5 controlled drug release. NLC4 allowed CAR permeation through porcine EP in greater amounts than NLC5, i.e. 11.83 ± 4.71 µg/cm2 compared to 3.06 ± 0.79 µg/cm2. NLC4 increased CARV permeation by 2.5-fold compared to the unloaded drug in rat skin studies (13.73 ± 4.12 versus 5.31 ± 1.56 µg/cm2). NLC4 seems to be a promising carrier for the transdermal delivery of CARV.